SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak sales of around $400 million in anaphylaxis treatment.

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Investing.com -- Novo Nordisk (CSE: NOVOb) has been placed on JPMorgan’s Catalyst Watch list, signaling heightened anticipation as the company approaches a pivotal moment in its development pipeline.

Investing.com -- US stock futures rose Monday, at the start of the new week that includes key inflation data as well as an abundance of Federal Reserve speakers. Here are some of the biggest premarket ...

(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk (NYSE: NVO )'s highly in-demand drugs for diabetes and weight loss, according to a review of patient data ...

The stock is now heading for an eye-popping annual gain of over ... First, let's consider some background on this specific ...

Eli Lilly (NYSE: LLY) and Novo Nordisk(NYSE: NVO), the kings of the titanic weight ... Short-term price changes shouldn't have anything to do with an investment thesis for either stock. Still, ...

If you looked solely at its stock price, you might get the idea that Eli Lilly (NYSE: LLY) is having a bit of an off quarter.